Loeb Partners’s Celgene CELG Stock Holding History
Bought
Maintained
Sold
Other funds holding CELG
Loeb Partners's CELG Position: Q2 2019 in Review
Loeb Partners sold out of Celgene (CELG) in Q2 2019, closing a stake of 200 shares — an estimated $18K sold.
Loeb Partners first reported a position in CELG in Q4 2015 and held it in 10 quarters. The position peaked at $810K in Q4 2016. 1,287 funds tracked by Wall St. Rank hold CELG as of Q2 2019.
- Loeb Partners reported no remaining Celgene position as of Q2 2019 after selling out during the quarter.
- Loeb Partners sold 200 Celgene shares in Q2 2019, an estimated $18K.
- Loeb Partners first reported a position in Celgene in Q4 2015 and held it in 10 quarters.
- Loeb Partners's Celgene position peaked at $810K in Q4 2016.
- 1,287 funds tracked by Wall St. Rank held Celgene as of Q2 2019.
Based on Loeb Partners's 13F filing for Q2 2019.